We are live on ! Find out more
GUTS icon

Fractyl Health

65 hedge funds and large institutions have $29.7M invested in Fractyl Health in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 17

0% more funds holding

Funds holding: 6565 (0)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

2.86% less ownership

Funds ownership: 53.85%50.99% (-2.9%)

44% less capital invested

Capital invested by funds: $53.4M → $29.7M (-$23.7M)

Holders
65
Holders Change
Holders Change %
0%
% of All Funds
0.87%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
7
Increased
20
Reduced
17
Closed
7
Calls
Puts
Net Calls
Net Calls Change

GUTS Hedge Fund Activity: Q1 2025 in Review

65 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Fractyl Health (GUTS) for Q1 2025, worth a combined $29.7M — down 44% from $53.4M a quarter earlier.

Fund positioning in GUTS was balanced in Q1 2025: 7 funds opened new positions, 7 closed out, 20 added to existing stakes and 17 trimmed.

The largest buyer was Woodline Partners, adding an estimated $265K. The largest seller was Citadel Advisors, cutting an estimated $1.01M.

  • 65 institutional investors held Fractyl Health (GUTS) as of Q1 2025, unchanged from Q4 2024.
  • Funds reported $29.7M of Fractyl Health stock for Q1 2025, down 44% quarter-over-quarter.
  • 7 funds opened new Fractyl Health positions in Q1 2025 and 7 closed out, a net change of 0 holders.
  • The largest Fractyl Health buyer in Q1 2025 was Woodline Partners, an estimated $265K added.
  • The largest Fractyl Health seller in Q1 2025 was Citadel Advisors, an estimated $1.01M sold.

Based on aggregated 13F filings for Q1 2025.